A Transcriptionally Active DNA-Binding Site for Human p53 Protein Complexes

References

• Baker, S. J., S. Markowitz, E. R. Fearon, J. K. V. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–915.
   PubMed Web of Science ®Google Scholar
• Bargonetti, J., P. N. Friedman, S. E. Kern, B. Vogelstein, and C. Prives. 1991. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell 65:1083–1091.
   PubMed Web of Science ®Google Scholar
• Blackwell, Τ. Κ., and H. Weintraub. 1990. Differences and similarities in DNA-binding preferences of myoD and E2A protein complexes revealed by binding site selection. Science 250:1104–1110.
   PubMed Web of Science ®Google Scholar
• Bodner, S., J. D. Minna, S. M. Jensen, D. D’Amico, T. Mitsudomi, J. Fedorko, Μ. Μ. Nau, and A. F. Gazdar. Expression of mutant p53 proteins correlates with the class of p53 gene mutation. Oncogene, in press.
   Google Scholar
• Braithwaite, A. W., H.-W. Sturzbecher, C. Addison, C. Palmer, K. Rudge, and J. R. Jenkins. 1987. Mouse p53 inhibits SV40 origin-dependent DNA replication. Nature (London) 329:458–460.
   PubMed Web of Science ®Google Scholar
• Buskin, J. N., and S. D. Hauschka. 1989. Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse creatine kinase gene. Mol. Cell. Biol. 9:2627–2640.
   PubMedGoogle Scholar
• Chittenden, T., D. M. Livingston, and W. G. Kaelin. 1991. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65:1073–1082.
   PubMed Web of Science ®Google Scholar
• Clarke, C. F., K. Cheng, A. B. Frey, R. Stein, P. W. Hinds, and A. J. Levine. 1988. Purification of complexes of nuclear oncogene p53 with rat and Escherichia coli heat shock proteins: in vitro dissociation of hsc70 and dnaK from murine p53 by ATP. Mol. Cell. Biol. 8:1206–1215.
   PubMed Web of Science ®Google Scholar
• DeWet, J. R., K. V. Wood, M. DeLuca, D. R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725–737.
   PubMed Web of Science ®Google Scholar
• Ellington, A. D., and J. W. Szostak. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature (London) 346:818–822.
   PubMed Web of Science ®Google Scholar
• Fields, S., and S. K. Jang. 1990. Presence of a potent transcriptional activating sequence in the p53 protein. Science 249:1046–1049.
   PubMed Web of Science ®Google Scholar
• Funk, W. D., and W. E. Wright. Unpublished data.
   Google Scholar
• Gannon, J. V., and D. P. Lane. 1987. p53 and DNA polymerase α compete for binding to SV40 Τ antigen. Nature (London) 329:456–458.
   PubMed Web of Science ®Google Scholar
• Ginsberg, D., F. Mechta, Y. Moshe, and M. Oren. 1991. Wild type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88:9979–9983.
   PubMed Web of Science ®Google Scholar
• Hara, E., H. Tsurui, A. Shiozaki, S. Nakada, and K. Oda. 1991. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179:528–534.
   PubMed Web of Science ®Google Scholar
• Johnson, P. F., and S. L. McKnight. 1989. Eukaryotic transcription regulatory proteins. Annu. Rev. Biochem. 58:799–839.
   PubMed Web of Science ®Google Scholar
• Kato, S., L. Tora, J. Yamauchi, S. Masushige, M. Bellard, and P. A. Chambon. 1992. Far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically. Cell 68:731–742.
   PubMed Web of Science ®Google Scholar
• Kern, S. E., K. W. Kinzler, S. J. Baker, J. M. Nigro, V. Rotter, A. J. Levine, P. Friedman, and B. Vogelstein. 1991. Mutant p53 proteins bind DNA abnormally in vitro. Oncogene 6:131–136.
   PubMed Web of Science ®Google Scholar
• Kern, S. E., K. W. Kinzler, A. Bruskin, D. Jarosz, P. Friedman, C. Prives, and B. Vogelstein. 1991. Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708–1711.
   PubMed Web of Science ®Google Scholar
• Kraiss, S., A. Quaiser, M. Oren, and M. Montenarh. 1988. Oligomerization of oncoprotein p53. J. Virol. 62:4737–4744.
   PubMed Web of Science ®Google Scholar
• Lane, D. P., and J. H. Gannon. 1983. Cellular proteins involved in SV40 transformation. Cell. Biol. Int. Rep. 7:513–514.
   Google Scholar
• Lassar, A. B., R. L. Davis, W. E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, and H. Weintraub. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305–315.
   PubMed Web of Science ®Google Scholar
• Levine, A. J., J. Momand, and C. A. Finlay. 1991. The p53 tumor suppressor gene. Nature (London) 351:453–455.
   PubMed Web of Science ®Google Scholar
• Mermod, N., E. A. O’Neill, T. J. Kelley, and R. Tjian. 1989. The proline-rich transcriptional activator of CTF/NF-1 is distinct from the replication and DNA binding domain. Cell 58:741–753.
   PubMed Web of Science ®Google Scholar
• Minna, J. D. (University of Texas Southwestern Medical Center at Dallas). Personal communication.
   Google Scholar
• O’Rourke, R. W., C. W. Miller, G. J. Kato, K. J. Simon, D. L. Chen, C. V. Dang, and P. Koeffler. 1990. A potent transcriptional activation element in the p53 protein. Oncogene 5:1829–1832.
   PubMedGoogle Scholar
• Raycroft, L., J. R. Schmidt, K. Yoas, M. Hao, and G. Lozano. 1991. Analysis of p53 mutants for transcriptional activity. Mol. Cell. Biol. 11:6067–6074.
   PubMedGoogle Scholar
• Raycroft, L., H. Wu, and G. Lozano. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049–1051.
   PubMed Web of Science ®Google Scholar
• Rio, D., and R. Tjian. 1983. SV40 Τ antigen binding site mutations that affect autoregulation. Cell 32:1227–1240.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Santhanam, U., A. Ray, and P. B. Sehgal. 1991. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 88:7605–7609.
   PubMed Web of Science ®Google Scholar
• Schmieg, F. I., and D. T. Simmons. 1988. Characterization of the in vitro interaction between SV40 Τ antigen and p53: mapping the p53 binding site. Virology 164:132–140.
   PubMedGoogle Scholar
• Shay, J. W., O. M. Pereira-Smith, and W. E. Wright. 1991. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196:33–39.
   PubMed Web of Science ®Google Scholar
• Shohat Foord, O., P. Bhattacharya, Z. Reich, and V. Rotter. 1991. A DNA binding domain is contained in the C-terminus of wild type p53 protein. Nucleic Acids Res. 19:5191–5198.
   PubMedGoogle Scholar
• Sompayrac, L., and K. J. Danna. 1990. Method to identify genomic targets of DNA binding proteins. Proc. Natl. Acad. Sci. USA 87:3274–3278.
   PubMedGoogle Scholar
• Steinmeyer, K., and W. Deppert. 1988. DNA binding properties of murine p53. Oncogene 3:501–507.
   PubMedGoogle Scholar
• Stenger, J. E., G. A. Mayr, K. Mann, and P. Tegtmeyer. 1992. Formation of stable p53 homotetramers and multiples of tetramers. Mol. Carcinog. 5:102–106.
   PubMedGoogle Scholar
• Sturzbecher, H.-W., P. Chumakov, W. J. Welch, and J. R. Jenkins. 1987. Mutant p53 proteins bind hsp72/73 cellular heat shock-related proteins in SV40 transfected monkey cells. Oncogene 1:201–211.
   PubMed Web of Science ®Google Scholar
• Takahashi, T., M. M. Nau, I. Chiba, M. J. Birrer, R. K. Rosenberg, M. Vinocour, M. Levitt, H. Pass, A. F. Gazdar, and J. D. Minna. 1989. p53: a frequent target for genetic abnormalities in lung cancer. Science 246:491–494.
   PubMed Web of Science ®Google Scholar
• Tuerk, C., and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510.
   PubMed Web of Science ®Google Scholar
• Wang, E. H., P. N. Friedman, and C. Prives. 1989. The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large Τ antigen. Cell 57:379–392.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1991. Tumor suppressor genes. Science 254:1138–1146.
   PubMed Web of Science ®Google Scholar
• Weintraub, H., S. Hauschka, and S. J. Tapscott. 1991. The MCK enhancer contains a p53 responsive element. Proc. Natl. Acad. Sci. USA 88:4570–4571.
   PubMed Web of Science ®Google Scholar
• Williams, R. S. (University of Texas, Southwestern Medical Center at Dallas). Unpublished data.
   Google Scholar
• Wright, W. Ε., Μ. Binder, and W. D. Funk. 1991. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell. Biol. 11:4104–4110.
   PubMed Web of Science ®Google Scholar
• Yewdell, J. W., J. V. Gannon, and D. P. Lane. 1986. Monoclonal antibody analysis of p53 expression in normal and transfected cells. J. Virol. 59:444–452.
   PubMed Web of Science ®Google Scholar